 Jason Aoto
Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nerve Tissue Proteins | 10 | 2023 | 551 | 2.810 |
Why?
| | Hippocampus | 13 | 2023 | 735 | 2.050 |
Why?
| | Synaptic Transmission | 10 | 2021 | 239 | 1.890 |
Why?
| | Neurons | 9 | 2023 | 1345 | 1.690 |
Why?
| | Receptors, AMPA | 8 | 2021 | 125 | 1.680 |
Why?
| | Synapses | 13 | 2023 | 344 | 1.460 |
Why?
| | Interneurons | 3 | 2021 | 103 | 1.090 |
Why?
| | GABAergic Neurons | 1 | 2021 | 21 | 0.820 |
Why?
| | Presynaptic Terminals | 1 | 2021 | 58 | 0.800 |
Why?
| | Nucleus Accumbens | 1 | 2023 | 131 | 0.800 |
Why?
| | Neural Inhibition | 1 | 2021 | 160 | 0.760 |
Why?
| | Cytological Techniques | 1 | 2020 | 24 | 0.750 |
Why?
| | Synaptic Vesicles | 2 | 2019 | 38 | 0.740 |
Why?
| | Protein Aggregates | 1 | 2020 | 70 | 0.710 |
Why?
| | Calcium | 3 | 2023 | 1169 | 0.700 |
Why?
| | Cell Communication | 1 | 2020 | 281 | 0.660 |
Why?
| | gamma-Aminobutyric Acid | 3 | 2023 | 155 | 0.590 |
Why?
| | Alternative Splicing | 2 | 2019 | 193 | 0.560 |
Why?
| | Olfactory Bulb | 2 | 2015 | 125 | 0.490 |
Why?
| | Cell Adhesion Molecules, Neuronal | 3 | 2023 | 35 | 0.490 |
Why?
| | Long-Term Potentiation | 3 | 2023 | 148 | 0.460 |
Why?
| | Mice | 13 | 2023 | 15520 | 0.390 |
Why?
| | Tretinoin | 2 | 2008 | 116 | 0.390 |
Why?
| | HEK293 Cells | 4 | 2020 | 625 | 0.380 |
Why?
| | Glutamic Acid | 3 | 2023 | 224 | 0.360 |
Why?
| | Animals | 18 | 2023 | 33381 | 0.360 |
Why?
| | Ligands | 2 | 2023 | 567 | 0.360 |
Why?
| | Neuronal Plasticity | 2 | 2008 | 219 | 0.360 |
Why?
| | Neural Cell Adhesion Molecules | 3 | 2019 | 24 | 0.340 |
Why?
| | Pyramidal Cells | 1 | 2008 | 54 | 0.330 |
Why?
| | Ephrin-B3 | 1 | 2007 | 1 | 0.310 |
Why?
| | Ephrins | 1 | 2006 | 6 | 0.300 |
Why?
| | Epilepsy | 2 | 2021 | 290 | 0.290 |
Why?
| | Mice, Knockout | 4 | 2021 | 2680 | 0.280 |
Why?
| | Signal Transduction | 6 | 2016 | 4709 | 0.230 |
Why?
| | Calcium-Binding Proteins | 4 | 2019 | 217 | 0.230 |
Why?
| | Receptors, Dopamine | 1 | 2023 | 13 | 0.230 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 4908 | 0.220 |
Why?
| | Receptors, GABA-A | 1 | 2023 | 89 | 0.220 |
Why?
| | Cells, Cultured | 7 | 2019 | 4077 | 0.220 |
Why?
| | Parvalbumins | 1 | 2021 | 19 | 0.210 |
Why?
| | Optogenetics | 2 | 2023 | 96 | 0.210 |
Why?
| | GABA Plasma Membrane Transport Proteins | 1 | 2021 | 5 | 0.210 |
Why?
| | Inhibitory Postsynaptic Potentials | 1 | 2021 | 32 | 0.210 |
Why?
| | Protein Transport | 2 | 2021 | 412 | 0.200 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 159 | 0.200 |
Why?
| | Autistic Disorder | 2 | 2015 | 168 | 0.200 |
Why?
| | Parasympathetic Nervous System | 1 | 2021 | 25 | 0.200 |
Why?
| | Motor Disorders | 1 | 2021 | 16 | 0.190 |
Why?
| | Substantia Nigra | 1 | 2021 | 38 | 0.190 |
Why?
| | Parkinsonian Disorders | 1 | 2021 | 29 | 0.190 |
Why?
| | Gene Knockdown Techniques | 2 | 2019 | 311 | 0.190 |
Why?
| | Cell Aggregation | 1 | 2020 | 24 | 0.190 |
Why?
| | Neurodevelopmental Disorders | 1 | 2021 | 116 | 0.180 |
Why?
| | Astrocytes | 1 | 2021 | 177 | 0.180 |
Why?
| | Dimerization | 1 | 2019 | 183 | 0.170 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2019 | 105 | 0.170 |
Why?
| | Genetic Engineering | 1 | 2019 | 83 | 0.170 |
Why?
| | Primary Cell Culture | 1 | 2019 | 155 | 0.170 |
Why?
| | Lipoylation | 1 | 2018 | 16 | 0.170 |
Why?
| | Integrases | 1 | 2019 | 123 | 0.170 |
Why?
| | Receptors, Retinoic Acid | 2 | 2008 | 41 | 0.170 |
Why?
| | Recombination, Genetic | 1 | 2019 | 173 | 0.170 |
Why?
| | Membrane Proteins | 3 | 2015 | 1055 | 0.160 |
Why?
| | Cell Membrane Permeability | 1 | 2018 | 88 | 0.160 |
Why?
| | Botulinum Toxins | 1 | 2019 | 40 | 0.160 |
Why?
| | Intellectual Disability | 1 | 2019 | 136 | 0.160 |
Why?
| | Gene Knock-In Techniques | 2 | 2019 | 47 | 0.160 |
Why?
| | A Kinase Anchor Proteins | 1 | 2018 | 72 | 0.160 |
Why?
| | Mutation, Missense | 1 | 2019 | 300 | 0.150 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2019 | 191 | 0.150 |
Why?
| | Sex Characteristics | 1 | 2021 | 671 | 0.150 |
Why?
| | Protein Biosynthesis | 2 | 2008 | 397 | 0.140 |
Why?
| | Cell Adhesion Molecules | 1 | 2016 | 180 | 0.130 |
Why?
| | Endocannabinoids | 1 | 2015 | 37 | 0.130 |
Why?
| | Capillaries | 3 | 2005 | 103 | 0.130 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 187 | 0.130 |
Why?
| | Models, Biological | 2 | 2015 | 1715 | 0.120 |
Why?
| | Sequence Analysis, RNA | 1 | 2016 | 409 | 0.120 |
Why?
| | Neural Pathways | 1 | 2015 | 277 | 0.120 |
Why?
| | Male | 5 | 2023 | 57801 | 0.110 |
Why?
| | Neovascularization, Physiologic | 2 | 2005 | 181 | 0.110 |
Why?
| | Female | 5 | 2023 | 61564 | 0.110 |
Why?
| | Rats | 3 | 2019 | 5392 | 0.110 |
Why?
| | Endocytosis | 1 | 2013 | 156 | 0.110 |
Why?
| | Retinoic Acid Receptor alpha | 2 | 2008 | 11 | 0.110 |
Why?
| | Carrier Proteins | 2 | 2023 | 726 | 0.100 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 3 | 2019 | 219 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2012 | 442 | 0.090 |
Why?
| | Cryptochromes | 2 | 2019 | 23 | 0.090 |
Why?
| | Transfection | 2 | 2008 | 888 | 0.080 |
Why?
| | Arabidopsis Proteins | 2 | 2019 | 59 | 0.080 |
Why?
| | Organ Culture Techniques | 1 | 2008 | 149 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2478 | 0.080 |
Why?
| | Patch-Clamp Techniques | 1 | 2008 | 247 | 0.080 |
Why?
| | Dendrites | 1 | 2008 | 88 | 0.080 |
Why?
| | Mutation | 2 | 2015 | 3457 | 0.080 |
Why?
| | Receptor, Notch1 | 2 | 2005 | 65 | 0.080 |
Why?
| | Receptors, Notch | 2 | 2005 | 85 | 0.080 |
Why?
| | Mental Disorders | 1 | 2015 | 939 | 0.070 |
Why?
| | Electrophysiology | 1 | 2007 | 204 | 0.070 |
Why?
| | Microscopy, Electron | 1 | 2007 | 413 | 0.070 |
Why?
| | Humans | 11 | 2021 | 118972 | 0.070 |
Why?
| | Tissue Distribution | 1 | 2007 | 334 | 0.070 |
Why?
| | Light | 2 | 2019 | 342 | 0.070 |
Why?
| | RNA, Small Interfering | 1 | 2008 | 564 | 0.070 |
Why?
| | Up-Regulation | 1 | 2008 | 872 | 0.070 |
Why?
| | Neurotransmitter Agents | 2 | 2015 | 76 | 0.070 |
Why?
| | Homeostasis | 1 | 2008 | 594 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2007 | 404 | 0.060 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1691 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 2 | 2003 | 527 | 0.060 |
Why?
| | Receptors, Neurotransmitter | 1 | 2023 | 16 | 0.060 |
Why?
| | Angiopoietin-1 | 1 | 2003 | 10 | 0.060 |
Why?
| | Angiogenesis Inducing Agents | 1 | 2003 | 24 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor Receptor-2 | 1 | 2003 | 86 | 0.060 |
Why?
| | Fibrin | 1 | 2003 | 60 | 0.060 |
Why?
| | Fibroblasts | 2 | 2003 | 842 | 0.050 |
Why?
| | Neostriatum | 1 | 2021 | 30 | 0.050 |
Why?
| | Acetylcholine | 1 | 2021 | 208 | 0.050 |
Why?
| | Umbilical Veins | 3 | 2005 | 59 | 0.050 |
Why?
| | Cell Compartmentation | 1 | 2019 | 53 | 0.040 |
Why?
| | Recombinant Proteins | 2 | 2019 | 1308 | 0.040 |
Why?
| | Learning | 1 | 2023 | 374 | 0.040 |
Why?
| | RNA Splice Sites | 1 | 2019 | 35 | 0.040 |
Why?
| | Vesicle-Associated Membrane Protein 2 | 1 | 2019 | 15 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1633 | 0.040 |
Why?
| | SNARE Proteins | 1 | 2019 | 37 | 0.040 |
Why?
| | Dendritic Spines | 1 | 2018 | 52 | 0.040 |
Why?
| | Dopamine | 1 | 2021 | 249 | 0.040 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2018 | 140 | 0.040 |
Why?
| | Protein Binding | 1 | 2023 | 1975 | 0.040 |
Why?
| | Endosomes | 1 | 2018 | 128 | 0.040 |
Why?
| | Behavior, Animal | 1 | 2021 | 486 | 0.040 |
Why?
| | Endothelium, Vascular | 1 | 2003 | 907 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2016 | 51 | 0.040 |
Why?
| | Databases, Factual | 1 | 2021 | 1231 | 0.040 |
Why?
| | Exocytosis | 1 | 2016 | 88 | 0.030 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2015 | 9 | 0.030 |
Why?
| | Guanylate Kinases | 1 | 2015 | 14 | 0.030 |
Why?
| | Glycerides | 1 | 2015 | 14 | 0.030 |
Why?
| | Human Embryonic Stem Cells | 1 | 2015 | 19 | 0.030 |
Why?
| | Arachidonic Acids | 1 | 2015 | 57 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2019 | 287 | 0.030 |
Why?
| | Enzyme Stability | 1 | 2015 | 75 | 0.030 |
Why?
| | Gene Targeting | 1 | 2015 | 80 | 0.030 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 1 | 2015 | 17 | 0.030 |
Why?
| | Gene Knockout Techniques | 1 | 2015 | 105 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2016 | 443 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2016 | 239 | 0.030 |
Why?
| | Heterozygote | 1 | 2015 | 262 | 0.030 |
Why?
| | Mice, Inbred Strains | 1 | 2015 | 405 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1489 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 356 | 0.030 |
Why?
| | Cell Membrane | 1 | 2015 | 710 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2071 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 460 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2871 | 0.020 |
Why?
| | Nerve Net | 1 | 2012 | 232 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2016 | 1597 | 0.020 |
Why?
| | Cytoplasmic Granules | 1 | 2008 | 84 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2015 | 1753 | 0.020 |
Why?
| | Phenotype | 1 | 2015 | 3003 | 0.020 |
Why?
| | Aspartic Acid Endopeptidases | 1 | 2005 | 22 | 0.020 |
Why?
| | Serrate-Jagged Proteins | 1 | 2005 | 30 | 0.020 |
Why?
| | Dipeptides | 1 | 2005 | 51 | 0.020 |
Why?
| | Carbamates | 1 | 2005 | 37 | 0.020 |
Why?
| | Endopeptidases | 1 | 2005 | 73 | 0.020 |
Why?
| | Oligonucleotides, Antisense | 1 | 2005 | 100 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 2005 | 173 | 0.020 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2005 | 76 | 0.020 |
Why?
| | Placenta Growth Factor | 1 | 2003 | 25 | 0.020 |
Why?
| | Receptor, Notch4 | 1 | 2003 | 3 | 0.010 |
Why?
| | Pregnancy Proteins | 1 | 2003 | 38 | 0.010 |
Why?
| | Flavonoids | 1 | 2003 | 71 | 0.010 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2003 | 67 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 116 | 0.010 |
Why?
| | Gels | 1 | 2003 | 72 | 0.010 |
Why?
| | Blood Vessels | 1 | 2005 | 187 | 0.010 |
Why?
| | Microspheres | 1 | 2003 | 130 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 154 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2005 | 316 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 369 | 0.010 |
Why?
| | Cell Division | 1 | 2005 | 776 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 173 | 0.010 |
Why?
| | Adenoviridae | 1 | 2003 | 191 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 982 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2003 | 174 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 298 | 0.010 |
Why?
| | Drosophila Proteins | 1 | 2003 | 171 | 0.010 |
Why?
| | Green Fluorescent Proteins | 1 | 2003 | 395 | 0.010 |
Why?
| | Receptors, Cell Surface | 1 | 2003 | 367 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 827 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2003 | 618 | 0.010 |
Why?
| | Endothelial Cells | 1 | 2005 | 732 | 0.010 |
Why?
| | Cell Movement | 1 | 2003 | 896 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1945 | 0.010 |
Why?
| | Skin | 1 | 2003 | 657 | 0.010 |
Why?
| | Cell Line | 1 | 2003 | 2707 | 0.010 |
Why?
| | Transcription Factors | 1 | 2003 | 1570 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2003 | 5255 | 0.010 |
Why?
|
|
Aoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|